Analysis of newly identified adhesin used by pathogenic Gram-negative bacteria
致病性革兰氏阴性菌使用的新发现的粘附素的分析
基本信息
- 批准号:8518227
- 负责人:
- 金额:$ 22.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdhesionsAnimalsAttenuatedBacteriaBacterial AdhesinsBacterial InfectionsBacterial TypingBindingBiochemicalBiologicalCell Adhesion MoleculesCell-Matrix JunctionCellsConsumptionCytoskeletonFibronectin ReceptorsFibronectinsFoundationsFutureGastroenteritisGenesGoalsGram-Negative BacteriaHemolysinInfectionInvestigationLeadLipidsMediatingMembrane ProteinsPhosphatidic AcidProductionProteinsReceptor CellRecombinantsRoleSeafoodSignal PathwaySignal TransductionStagingSurfaceType III Secretion System PathwayVibrio parahaemolyticuscytotoxicityinhibitor/antagonistinsightinterestnovelpathogenprotein protein interactionreceptorresearch study
项目摘要
DESCRIPTION (provided by applicant): The aim of this proposal is to characterize a newly multivalent adhesion molecule (MAM7) found in the majority of Gram-negative pathogenic animal bacteria. We propose that MAM7 is involved in the initial contact of bacterial pathogens with host cells. As a representative for this type of molecule, we will use the MAM7 protein from Vibrio parahaemolyticus, an emerging pathogen that causes gastroenteritis through consumption of raw or undercooked seafood, to study the multivalent binding to host cells. We observe MAM7 dependent changes in the actin cytoskeleton in host cells. We predict that binding of MAM7 will trigger the production of more adhesion factors in the bacterial pathogens. Thus as one of our aims, we would like to uncover the signaling machinery activated in the bacteria and the host cell upon binding of MAM7. In another aim, we would like to understand the biochemical interaction of MAM7 with its two host cell receptors, fibronectin and phosphatidic acid. This information will be extremely valuable for future studies focused on MAM7 inhibitors. Finally, we observe that binding of non-pathogenic bacteria expressing MAM7 (BL21-MAM7) to host cells ameliorates cytotoxicity of Gram-negative pathogens expressing MAM7. We are interested in determining how broadly MAM7 provides a competitive advantage over other types of bacterial pathogens that do not express MAM7 but other types of adhesins. Together, these experiments will allow us to characterize the newly identified multivalent adhesion molecule MAM7 and will help to elucidate its value as a competitive inhibitor for a wide variety of bacterial pathogens.
描述(由申请人提供):该提案的目的是表征大多数革兰氏阴性致病动物细菌中新近多价粘附分子(MAM7)。我们建议MAM7参与细菌病原体与宿主细胞的初始接触。作为这种类型分子的代表性,我们将使用来自Vibrio Parahayticus的MAM7蛋白,这是一种新兴的病原体,通过消耗原始或未煮熟的海鲜引起胃肠炎,研究与宿主细胞的多价结合。我们观察到宿主细胞中肌动蛋白细胞骨架的MAM7依赖性变化。我们预测MAM7的结合将触发细菌病原体中更多粘附因子的产生。因此,作为我们的目标之一,我们希望在MAM7结合后发现在细菌和宿主细胞中激活的信号机制。在另一个目的中,我们想了解MAM7与其两个宿主细胞受体的生化相互作用:纤连蛋白和磷脂酸。对于关注MAM7抑制剂的未来研究,此信息将非常有价值。最后,我们观察到表达MAM7(BL21-MAM7)宿主细胞的非致病细菌的结合可以改善表达MAM7的革兰氏阴性病原体的细胞毒性。我们有兴趣确定与其他类型的细菌病原体相比,MAM7如何提供竞争优势,这些细菌病原体不会表达MAM7而不是其他类型的粘附素。总之,这些实验将使我们能够表征新鉴定的多价粘附分子MAM7,并有助于阐明其作为多种细菌病原体的竞争抑制剂的价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kim Orth其他文献
Kim Orth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kim Orth', 18)}}的其他基金
FASEB's The Microbial Pathogenesis Conference: Mechanisms of Infectious Disease
FASEB 微生物发病机制会议:传染病机制
- 批准号:
10228853 - 财政年份:2021
- 资助金额:
$ 22.42万 - 项目类别:
Biochemistry, biology and diversity of Fic domains
生物化学、生物学和 Fic 领域的多样性
- 批准号:
10550154 - 财政年份:2020
- 资助金额:
$ 22.42万 - 项目类别:
Biochemistry, biology and diversity of Fic domains
生物化学、生物学和 Fic 领域的多样性
- 批准号:
10334464 - 财政年份:2020
- 资助金额:
$ 22.42万 - 项目类别:
Biochemistry, biology and diversity of Fic domains
生物化学、生物学和 Fic 领域的多样性
- 批准号:
10092197 - 财政年份:2020
- 资助金额:
$ 22.42万 - 项目类别:
Proteostasis, AMPylation and the Unfolded Protein repsonse (UPR)
蛋白质稳态、AMPylation 和未折叠蛋白反应 (UPR)
- 批准号:
9229559 - 财政年份:2015
- 资助金额:
$ 22.42万 - 项目类别:
Proteostasis, AMPylation and the Unfolded Protein repsonse (UPR)
蛋白质稳态、AMPylation 和未折叠蛋白反应 (UPR)
- 批准号:
8914100 - 财政年份:2015
- 资助金额:
$ 22.42万 - 项目类别:
Analysis of newly identified adhesin used by pathogenic Gram-negative bacteria
致病性革兰氏阴性菌使用的新发现的粘附素的分析
- 批准号:
8304009 - 财政年份:2012
- 资助金额:
$ 22.42万 - 项目类别:
Analysis of an orchestrated cell death mediated by Vibrio parahaemolytics T3SS1
副溶血弧菌 T3SS1 介导的精心策划的细胞死亡分析
- 批准号:
8431443 - 财政年份:2010
- 资助金额:
$ 22.42万 - 项目类别:
Analysis of an orchestrated cell death mediated by Vibrio parahaemolytics T3SS1
副溶血弧菌 T3SS1 介导的精心策划的细胞死亡分析
- 批准号:
7867642 - 财政年份:2010
- 资助金额:
$ 22.42万 - 项目类别:
Analysis of an orchestrated cell death mediated by Vibrio parahaemolytics T3SS1
副溶血弧菌 T3SS1 介导的精心策划的细胞死亡分析
- 批准号:
8225260 - 财政年份:2010
- 资助金额:
$ 22.42万 - 项目类别:
相似国自然基金
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
载Pexidartinib的纳米纤维膜通过阻断CSF-1/CSF-1R通路抑制巨噬细胞活性预防心脏术后粘连的研究
- 批准号:82370515
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
泛素连接酶SMURF2通过SMAD6-COL5A2轴调控宫腔粘连纤维化的分子机制研究
- 批准号:82360301
- 批准年份:2023
- 资助金额:31 万元
- 项目类别:地区科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
膜仿生载基因纳米球体内重编程巨噬细胞抑制肌腱粘连的机制研究
- 批准号:82372389
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Elucidating the role of Myosin 5b in intestinal inflammation
阐明肌球蛋白 5b 在肠道炎症中的作用
- 批准号:
10883872 - 财政年份:2023
- 资助金额:
$ 22.42万 - 项目类别:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
白细胞整合素信号的改变导致糖尿病和自身免疫
- 批准号:
10502136 - 财政年份:2022
- 资助金额:
$ 22.42万 - 项目类别:
Single-component optogenetic tools to bidirectionally control RhoA in mechanotransduction
在力转导中双向控制 RhoA 的单组分光遗传学工具
- 批准号:
10521872 - 财政年份:2022
- 资助金额:
$ 22.42万 - 项目类别:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
白细胞整合素信号的改变导致糖尿病和自身免疫
- 批准号:
10683384 - 财政年份:2022
- 资助金额:
$ 22.42万 - 项目类别: